Reviva Pharmaceuticals Holdings, Inc.
RVPH
$0.7824
$0.073410.35%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -29.92M | -33.01M | -35.99M | -39.84M | -39.26M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 912.60K | 671.10K | 606.70K | 3.53M | 3.65M |
| Change in Net Operating Assets | -4.54M | -976.50K | 130.20K | 4.22M | 7.28M |
| Cash from Operations | -33.54M | -33.32M | -35.26M | -32.10M | -28.32M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 976.90K | 415.00K | 415.00K | 415.00K | 667.50K |
| Total Debt Repaid | -518.80K | -554.50K | -430.00K | -750.50K | -667.50K |
| Issuance of Common Stock | 23.19M | 34.05M | 30.30M | 33.15M | 33.17M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 23.65M | 33.91M | 30.28M | 32.82M | 33.17M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.89M | 586.50K | -4.97M | 718.10K | 4.85M |